GreenRoc Accelerates their World Class Project to Production as Early as 2028. Watch the full video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksYGEN.L Regulatory News (YGEN)

  • There is currently no data for YGEN

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Licensing agreement

28 Mar 2007 07:02

ViaLogy PLC28 March 2007 Date: 28 March 2007 On behalf of: ViaLogy plc ("ViaLogy" or "the Company") Embargoed until: 0700hrs ViaLogy PLC Technology Update o Vialogy combines technologies to detect Chemical, Biological,Radiological, Nuclear and Explosive materials ("CBRNE"). o Exclusive license from Oak Ridge National Laboratory ("ORNL") willenable detection of CBRNE material traces from 100 metres distance. LONDON, March 28, 2007 - Two breakthrough technologies are being combined byscientists in California to enable the detection of covert and camouflagedbuildings where explosives may be manufactured and stored. The hand-heldchemical detection device will also be able to identify dangerous compoundsbeing carried by people. The US subsidiary of ViaLogy PLC (LSE: VIY) in Altadena, CA, and UT Battelle LLC("UT Battelle"), of Oak Ridge, TN, have completed an agreement grantingexclusive commercialization rights for dual-beam Reverse Photo-AcousticSpectrometer ("REPAS") technology. UT-Battelle manages Oak Ridge NationalLaboratory ("ORNL") for the U.S. Department of Energy. Under this patentlicensing and commercialization agreement, ViaLogy will capitalize on thesynergy between ORNL's breakthrough REPAS technology and ViaLogy's advanced weaksignal processing for standoff detection of minute amounts of CBRNE materials. The REPAS methodology was invented by Dr Thomas Thundat and scientists Dr. MingSu and Dr. David Hedden. Dr. Thundat, who is a Corporate Fellow and Head ofORNL's Nanoscale Science and Device's Group, has demonstrated the potential toachieve ultra-long range detection of various explosives such as TNT, PETN (oneof the explosive materials in Semtex plastic explosives), and RDX, a majorcomponent of many plastic bonded explosives used in nuclear weapons. ViaLogyplans to combine its patented weak-signal technology, Quantum ResonanceInterferometry (QRI), with REPAS to build a device effective at distances of atleast 100 metres. Long range detection of CBRNE materials is an exceptionally challenging problemand an extremely high priority in the global war on terrorism. Accurateidentification of persons and facilities in cluttered urban environmentsinvolved in suspected bomb-making activities is critical. The recent increase ofterrorists using radio-controlled improvised explosive devices ("IEDs") andvehicle bombs has lead to significant losses in human lives and building damage. Current state-of-the-art explosive signature detection systems endanger bothsecurity personnel and civilians. ViaLogy aims to create a portable or mobileplatform-mounted system that can be used to rapidly scan human or buildingsurfaces from a secure distance. Any detected signature will immediatelytrigger actionable intelligence that can be used to identify, observe, monitor,track suspects, and/or neutralize personnel and facilities at a distance. "REPAS is a remarkable invention, and we are delighted to partner with ORNL inthe commercialization process," said ViaLogy's CEO, Michael Kelly. "IdentifyingCBRNE and IED assembly facilities from a distance is a technique that has neverbeen properly mastered. "Dr. Thundat and his team at Oak Ridge have now demonstrated that REPAS caneffectively identify unique chemical bonding signatures for explosives.Integration with the powerful QRI algorithm will significantly extend thedistance of coverage and enhance the signal-to-background ratio". Dr. Tom George, ViaLogy's Director for Product Development and Nanofabrication,will be leading the technology integration project. Dr. George previously headedthe MEMS Sensors and Technology group at NASA's Jet Propulsion Laboratory. Vialogy will be working with manufacturers and system integrators to fast trackproduction, certification and distribution of the ViaLogy REPAS systems. For further information please contact: ViaLogyMichael Kelly, CEO - US +1 626 296 6337Terry Bond, Chairman - UK & Europe +44 (0)20 7869 7014 Redleaf CommunicationsEmma Kane / Samantha Robbins +44 (0)20 7822 0200 Seymour Pierce LimitedMark Percy +44 (0)20 7107 8000 About ViaLogy: Network Centric Signal Processing. ViaLogy is a leading innovator of network-centric, real-time signal processingplatforms for sensor applications. ViaLogy is currently deploying and designingcomputational systems, powered by its patented technologies, for applications inlife sciences, public safety and security, surveillance, defense andgeoseismology. Vialogy focuses on market driven problems where automation,timeliness, quality and reliability of information processing are essential.ViaLogy's core competency incorporates rapidly and accurately detecting weaksignals buried in high noise background and clutter. This technology can beemployed to solve problems involving sensor integration and information overloadchallenges involving video, telephony and control sensors, as well as forenhancement of numerous signal processing applications. For more information,visit our website at www.vialogy.com. About UT-Batelle, LLC: A not-for-profit company, known as UT-Battelle, has beenestablished for the sole purpose of managing and operating the Oak RidgeNational Laboratory for the U.S. Department of Energy. Formed as a 50-50 limitedliability partnership between the University of Tennessee and Battelle,UT-Battelle is the legal entity responsible for leading ORNL as the Laboratoryenters the 21st Century. About ORNL: ORNL (www.ornl.gov) is a multiprogram science and technologylaboratory managed for the U.S. Department of Energy by UT-Battelle, LLC.Scientists and engineers at ORNL conduct basic and applied research anddevelopment to create scientific knowledge and technological solutions thatstrengthen the nation's leadership in key areas of science; increase theavailability of clean, abundant energy; restore and protect the environment; andcontribute to national security. ORNL also performs other work for theDepartment of Energy, including isotope production, information management, andtechnical program management, and provides research and technical assistance toother organizations. The laboratory is a program of DOE's Oak Ridge FieldOffice. Except for statements of historical fact, the information presented hereinconstitutes forward-looking statements within the meaning of the PrivateSecurities Litigation Reform Act of 1995. Such forward-looking statementsinvolve known and unknown risks, uncertainties and other factors which may causethe actual results, performance or achievements of the company to be materiallydifferent from any future results, performance or achievements expressed orimplied. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
15th May 20187:00 amRNSYear-end Trading Update and £2.5m Fundraising
30th Apr 20184:00 pmRNSNotice of Trading Update
29th Mar 20187:00 amRNSPremaitha to attend industry conferences in APAC
26th Mar 20187:00 amRNSUpdate on UK patent infringement claim
16th Feb 20187:00 amRNSPremaitha secures market entry into Egypt
14th Feb 201810:25 amRNSHolding(s) in Company
12th Feb 20187:00 amRNSThermo Fisher - issue of warrants
6th Feb 20187:00 amRNSPremaitha to attend key conferences in Middle East
5th Feb 20187:00 amRNSPremaitha's IONA test approved for sale in Brazil
24th Jan 20187:00 amRNSUK High Court grants right to appeal
22nd Jan 20187:00 amRNSSecured loan facility agreement with Thermo Fisher
29th Dec 20177:00 amRNSHalf Year Results
11th Dec 20177:00 amRNSPremaitha secures four further laboratories in EU
1st Dec 20179:40 amRNSPremaitha CEO Wins Outstanding Contribution Award
27th Nov 20177:00 amRNSMiddle East laboratory network expansion
23rd Nov 20177:00 amRNSPremaitha signs new partner in East Asia
21st Nov 201710:47 amRNSLitigation First Instance Judgment
30th Oct 201710:08 amRNSGrant of Share Options
24th Oct 20173:45 pmRNSResult of AGM
24th Oct 20177:00 amRNSAGM Statement
13th Oct 20177:00 amRNSMiddle East Update
29th Sep 20177:04 amRNSFinal Results
29th Sep 20177:01 amRNSNotice of AGM
21st Sep 20174:05 pmRNSHolding(s) in Company
19th Sep 20177:00 amRNSPremaitha to offer NIPT in South Africa
7th Sep 20173:10 pmRNSFurther Patent Infringement Claims
29th Aug 20177:00 amRNSApproved for Good Manufacturing Process in Brazil
18th Jul 20172:02 pmRNSHolding(s) in Company
12th Jul 20177:00 amRNSInvestment Agreement Extension with Thermo Fisher
10th Jul 20177:00 amRNSPremaitha announces two laboratory hub contracts
3rd Jul 20177:00 amRNSLitigation Update
27th Jun 20177:00 amRNSHolding(s) in Company
16th Jun 20177:00 amRNSPremaitha launches Sage NIPT solution
5th Jun 20177:00 amRNSIndia Business Update
26th May 20177:00 amRNSIONA test validation on Thermo Fisher's Ion S5
19th May 20172:30 pmRNSPremaitha welcomes NIPT recommendation in France
16th May 20177:00 amRNSYear End Trading Update
12th May 20172:15 pmRNSUpdate Re. Swiss Customer
3rd Apr 20174:48 pmRNSHolding(s) in Company
31st Mar 20174:00 pmRNSSecond tranche of warrants issued to Thermo Fisher
17th Mar 20177:15 amRNSHardman Research: Expanding global distribution
13th Mar 20177:00 amRNSPremaitha to Attend International Medical Events
2nd Mar 201711:03 amRNSCompletion of Yourgene Acquisition
27th Feb 20177:00 amRNSCompletion of Acquisition
22nd Feb 20179:37 amRNSHolding(s) in Company
20th Feb 20177:00 amRNSMiddle East Business Update
16th Feb 20175:34 pmRNSHolding(s) in Company
15th Feb 20177:00 amRNSIssue of Equity
14th Feb 20179:32 amRNSHolding(s) in Company
13th Feb 20177:00 amRNSNew partnership with European diagnostics group

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.